Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/20/2025 6:04:49 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 5340
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49763
I wish I knew all Kelt! The only concrete thing I
(4)
DaubersUP
10/11/2018 4:36:04 PM
49762
Couldn't have said it better myself. Tired of
(1)
Kelt
10/11/2018 4:34:15 PM
49761
Kelt, Leo cant use Aspire because the SP is
(1)
sox0407
10/11/2018 4:33:47 PM
49760
Shame that some people don't understand or
Kelt
10/11/2018 4:30:51 PM
49759
It doesn't matter what kind of a deal Leo makes,
(4)
Drano
10/11/2018 4:29:32 PM
49758
He didn't need to have the deal with Aspire this
Kelt
10/11/2018 4:26:06 PM
49757
Oh come on. The company is only taking 2.2
Drano
10/11/2018 4:24:57 PM
49756
If you don't think this is toxic financing you
bejamin
10/11/2018 4:18:21 PM
49755
I dont think we could rely on Aspire because the
(1)
Squar
10/11/2018 4:06:30 PM
49754
I may be wrong but Leo could have just continued
(6)
Kelt
10/11/2018 3:52:19 PM
49753
Great level headed info. Thank you. I also know
(6)
DaubersUP
10/11/2018 3:17:51 PM
49752
Daubers, great post over there! I doubt the MFO
(3)
sox0407
10/11/2018 3:02:41 PM
49751
Generous group of MM's filled my order today for
AlanC
10/11/2018 3:01:24 PM
49750
It's all about potential. $2b for this startup
(3)
smokenhot
10/11/2018 2:50:57 PM
49749
The financing deal this week makes it almost
Squar
10/11/2018 2:16:27 PM
49748
Daubers: IMHO Leo and team know exactly what is
(1)
AlanC
10/11/2018 2:03:53 PM
49747
Yes, Scotty is certainly in hot water over there.
Squar
10/11/2018 1:53:13 PM
49746
Ill be right there with you brother. Bought a
Squar
10/11/2018 1:50:09 PM
49745
According to 7th grad math class, 20 x 0 =
Drano
10/11/2018 1:49:42 PM
49744
The so-called Level 2 was showing over 50k on the
(1)
Drano
10/11/2018 1:49:07 PM
49743
I wish. That would make me a big winner. Then I
Squar
10/11/2018 1:48:19 PM
49742
Hey Squar you know TheBunny over at your main
(2)
smokenhot
10/11/2018 1:43:50 PM
49741
I going to be more than happy to sell those
(1)
Loose Lips
10/11/2018 1:42:54 PM
49740
Let me fix that for you. You meant to write "I
(2)
Drano
10/11/2018 1:35:56 PM
49739
Yeesh....I bought shares at 3.40. Now that's a
Squar
10/11/2018 1:35:04 PM
49738
Those might be some of the shares I bought. My
(2)
Loose Lips
10/11/2018 12:56:11 PM
49737
Daubers it's known we are waiting on BTD
smokenhot
10/11/2018 12:43:59 PM
49736
Agree that we have raised $ and should at least
(2)
zdubble17
10/11/2018 12:43:12 PM
49735
I go agree. Ive now added over 60K shares
(1)
DaubersUP
10/11/2018 12:36:59 PM
49734
DaubersUP even at 16 million shares, that is only
(1)
zdubble17
10/11/2018 12:14:59 PM
49733
Alan. We need a deal or some kind of promising
(1)
DaubersUP
10/11/2018 12:06:00 PM
49732
Volume was around 500k but has flatlined for
Drano
10/11/2018 11:39:30 AM
49731
At 11:30 or two hours into the trading day volume
AlanC
10/11/2018 11:33:54 AM
49730
I would buy the .17's and consider yourself
(3)
AlanC
10/11/2018 9:57:08 AM
49729
The financing deal put my solvency concerns to
(1)
Squar
10/11/2018 9:53:55 AM
49728
Convinced me to pick up a bit more here Zdub.
Squar
10/11/2018 9:51:30 AM
49727
Good point. I have always felt that as painful as
(4)
Loose Lips
10/11/2018 9:50:53 AM
49726
It is what it is.
Kelt
10/11/2018 9:16:58 AM
49725
Sub penny thoughts are a bunch of nonsense. That
scgmck1
10/11/2018 8:59:45 AM
49724
I think what cracks me up is that this company
(11)
zdubble17
10/11/2018 8:50:52 AM
49723
yeah that will show the crooks. I got my sub
(2)
Jimmyboy
10/11/2018 8:49:04 AM
49722
If they are foolish enough do that, they will
(2)
scgmck1
10/11/2018 8:36:33 AM
49721
Really? Squar don't show your motive that easy.
zdubble17
10/11/2018 8:28:11 AM
49720
Anyone have a guess on trading? Are 0.17s the buy
(2)
Squar
10/11/2018 7:58:02 AM
49719
Priority review accompanying BTD for B-OM - yes.
(1)
Squar
10/10/2018 10:13:29 PM
49718
Included in it is "Material threat medical
(1)
Squar
10/10/2018 10:08:50 PM
49717
DaubersUp in the Swamp had a good post. Yes there
(6)
Trading Pro Broker
10/10/2018 8:55:06 PM
49716
Priority Review could/would be used in the
Kelt
10/10/2018 8:49:09 PM
49715
This is the list of criteria for a drug to meet
(2)
Kelt
10/10/2018 8:43:51 PM
49714
42% marked today and this does not include the
(1)
AlanC
10/10/2018 5:46:54 PM
Newer
Older
Recent Articles
SharpLink's Stock Buyback Program: A Strategic Move Ahead
Elemental Altus Initiates Share Consolidation for Growth
RocketReach Unveils AI-Powered Features for Enhanced Outreach Success
Data Guardians Network Joins NVIDIA to Transform AI Governance
Energize Capital Strengthens Leadership with Alan Glass Appointment
Aurzen's Award-Winning ZIP Projector Redefines Home Cinema
Projected Growth of the U.S. Dermatology Market to $1 Billion
LA Semiconductor Accelerates Domestic Manufacturing with Fab Sale
Exploring the Biofilter Market Potential and Trends Ahead
ACORD Connect 2025: Bridging Collaboration in Insurance
Revolutionary Graphene Coating Could Change Electronic Cooling
Pacaso Introduces Innovative $100M Co-Ownership Mortgage Solution
Unlocking the Potential of Gnodi Blockchain: Mainnet Launch Insights
TIAA Expands Services with New Lending and Estate Planning Options
DIRTT Secures Major Projects, Expanding Opportunities in Construction
City of London Investment Group PLC Reports Strong Year-End Results
Paladin Energy Secures A$300 Million to Advance Uranium Projects
Jyong Biotech Achieves Major Milestone in Prostate Cancer Trial
Elevating Power Management: Microchip's DualPack 3 Modules
Adagene Enhances Partnership with Exelixis for Cancer Breakthrough
Oryzon Expands Patent Holdings for Key Oncological Treatments
Adial Pharmaceuticals Advances AD04 Following FDA Meeting
Intermex Enhances Payroll Card Program with No-Fee Wires Feature
Corbus Pharmaceuticals Advances CRB-701 for Cancer Treatment
Danti Launches Built-In Agents for Advanced Data Analysis Solutions
Transformative Effects of Elutia's Biologic Envelopes on CIEDs
Baylin Technologies Secures Major Contract for GaN SSPAs
Turbo Energy's Innovative $53 Million Solar Storage Project
Empowering Future Health Professionals in Injury Prevention
Izotropic Launches Comprehensive FAQ Resource for Investors
CO280 Solutions Begins Innovative Carbon Removal Project
Innovative Longevity World Cup Creates Excitement for Athletes
EagleNXT Elevates Brand Identity for Future Growth Opportunities
Imbria Pharmaceuticals Unveils Board Changes and Key Roles
Avadel Pharmaceuticals Marks Five Years of Sleep Research Funding
SpyGlass Pharma Welcomes Anand Sundaram as Commercial Leader
Aqua Metals Partners with Impossible Metals for Mineral Innovation
Electrosoft's Collaboration with NIST Enhances Cybersecurity Framework
Duos Technologies Expands with Fifth Edge Data Center Deployment
FDA's Positive Feedback Fuels Adial Pharmaceuticals' Developments
Hyperion DeFi Partners with Credo to Enhance Trading Efficiency
Join WorkFair 2025 for Global Job Opportunities for LGBTQ+ Talent
HCW Biologics Advances Promising Immunotherapy for Cancer Treatment
Autolus Therapeutics Shares Exciting CAR T-Cell Study Updates
Lucid Diagnostics Strengthens Leadership with Danielle Scelfo
Allied Properties Updates on Its Progress in Property Sales
Gotion High-Tech Powers ACWA's Groundbreaking Solar Projects
Precision Medicine Group Welcomes Tracey Leahy as CPO
Trump Advocates Six-Month Reporting Over Quarterly Reports
SCIENTURE's Strategic Agreement to Boost Arbli Market Access